1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 31
2.4 Emerging Opportunities and Market Trends 34
2.5 Porter's Fiver Forces Analysis 38
3 Segmentation of Global Market by Category 43
3.1 Market Overview by Category 43
3.2 Pharmaceutical Industry 45
3.3 Biopharmaceutical Industry 46
4 Segmentation of Global Market by Product 47
4.1 Market Overview by Product 47
4.2 Active Pharmaceutical Ingredients (API) 49
4.2.1 Branded API Manufacturing 50
4.2.2 Generic API Manufacturing 51
4.3 Finished Dosage Formulations (FDF) 52
4.3.1 Solid Dosage 54
4.3.2 Oral Liquids 55
4.3.3 Parenteral/Injectables 56
4.3.4 Other FDFs 57
4.4 Secondary Packaging 58
5 Segmentation of Global Market by Phase 59
5.1 Market Overview by Phase 59
5.2 Clinical Manufacturing 61
5.3 Commercial Manufacturing 62
6 Segmentation of Global Market by Type 63
6.1 Market Overview by Type 63
6.2 Sterile Products 65
6.3 Non-Sterile Products 66
7 Segmentation of Global Market by Therapeutic Application 67
7.1 Market Overview by Therapeutic Application 67
7.2 Infectious Diseases 69
7.3 Oncology 70
7.4 Metabolic Disorders 71
7.5 Cardiovascular Disorders 72
7.6 Central Nervous System 73
7.7 Pulmonary Disorders 74
7.8 Gastrointestinal Disorders 75
7.9 Other Therapeutic Applications 76
8 Segmentation of Global Market by Region 77
8.1 Geographic Market Overview 2019-2030 77
8.2 North America Market 2019-2030 by Country 81
8.2.1 Overview of North America Market 81
8.2.2 U.S. 85
8.2.3 Canada 89
8.2.4 Mexico 91
8.3 European Market 2019-2030 by Country 93
8.3.1 Overview of European Market 93
8.3.2 Germany 97
8.3.3 UK 99
8.3.4 France 101
8.3.5 Spain 103
8.3.6 Italy 105
8.3.7 Russia 107
8.3.8 Rest of European Market 109
8.4 Asia-Pacific Market 2019-2030 by Country 111
8.4.1 Overview of Asia-Pacific Market 111
8.4.2 Japan 115
8.4.3 China 118
8.4.4 Australia 121
8.4.5 India 123
8.4.6 South Korea 125
8.4.7 Rest of APAC Region 127
8.5 South America Market 2019-2030 by Country 129
8.5.1 Argentina 132
8.5.2 Brazil 134
8.5.3 Chile 136
8.5.4 Rest of South America Market 138
8.6 MEA Market 2019-2030 by Country 139
8.6.1 UAE 142
8.6.2 Saudi Arabia 144
8.6.3 South Africa 146
8.6.4 Other National Markets 148
9 Competitive Landscape 149
9.1 Overview of Key Vendors 149
9.2 New Product Launch, Partnership, Investment, and M&A 153
9.3 Company Profiles 154
Aenova Group 154
Baxter BioPharma Solutions 156
Boehringer Ingelheim 157
Catalent Inc. 158
Famar S.A. 159
Hospira, Inc. 160
Jubilant Life Sciences Ltd. 161
Lonza Group 162
Patheon Inc. 163
Pfizer CentreSource 164
Recipharm AB 165
Vetter Pharma International GmbH 166
10 Investing in Global Market: Risk Assessment and Management 167
10.1 Risk Evaluation of Global Market 167
10.2 Critical Success Factors (CSFs) 170
Related Reports and Products 173